W. K. Hong

601 total citations
9 papers, 465 citations indexed

About

W. K. Hong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, W. K. Hong has authored 9 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in W. K. Hong's work include Nutrition, Genetics, and Disease (2 papers), Glutathione Transferases and Polymorphisms (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). W. K. Hong is often cited by papers focused on Nutrition, Genetics, and Disease (2 papers), Glutathione Transferases and Polymorphisms (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). W. K. Hong collaborates with scholars based in United States. W. K. Hong's co-authors include E. S. Kim, Anne S. Tsao, Roy Herbst, Wilhelm G. Doos, J. Jack Lee, WN Hittelman, D. D. Liu, Vassiliki A. Papadimitrakopoulou, Julie Izzo and Adel K. El‐Naggar and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Journal of the Mechanics and Physics of Solids.

In The Last Decade

W. K. Hong

9 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. K. Hong United States 6 210 140 75 60 51 9 465
Su‐Yu Chien Taiwan 17 341 1.6× 96 0.7× 126 1.7× 32 0.5× 58 1.1× 21 640
Wanqi Zhu China 12 156 0.7× 100 0.7× 39 0.5× 112 1.9× 28 0.5× 30 560
Chien‐Yi Chan Taiwan 11 283 1.3× 62 0.4× 91 1.2× 36 0.6× 42 0.8× 22 510
Prashasnika Gehlot United States 7 189 0.9× 144 1.0× 85 1.1× 56 0.9× 38 0.7× 10 538
Man He China 8 216 1.0× 103 0.7× 105 1.4× 49 0.8× 35 0.7× 19 407
Guan-Cheng Huang Taiwan 14 183 0.9× 123 0.9× 48 0.6× 21 0.3× 51 1.0× 21 503
Linda A. Doody United States 8 146 0.7× 84 0.6× 66 0.9× 33 0.6× 31 0.6× 9 339
Shankar Jagadeesh United States 12 353 1.7× 56 0.4× 54 0.7× 60 1.0× 20 0.4× 18 537
Chinmay K. Panda India 12 217 1.0× 121 0.9× 98 1.3× 21 0.3× 19 0.4× 18 461
Hanxi Zhao China 12 158 0.8× 107 0.8× 43 0.6× 182 3.0× 30 0.6× 23 656

Countries citing papers authored by W. K. Hong

Since Specialization
Citations

This map shows the geographic impact of W. K. Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. K. Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. K. Hong more than expected).

Fields of papers citing papers by W. K. Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. K. Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. K. Hong. The network helps show where W. K. Hong may publish in the future.

Co-authorship network of co-authors of W. K. Hong

This figure shows the co-authorship network connecting the top 25 collaborators of W. K. Hong. A scholar is included among the top collaborators of W. K. Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. K. Hong. W. K. Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Komaki, Ritsuko, Ignacio I. Wistuba, Xi Tang, et al.. (2011). Abstract 2658: Phase II study of chemoradiation therapy and erlotinib for stage III non-small cell lung cancer. Cancer Research. 71(8_Supplement). 2658–2658. 1 indexed citations
2.
Hong, W. K., Z. Suo, & Zulin Zhang. (2007). Dynamics of terraces on a silicon surface due to the combined action of strain and electric current. Journal of the Mechanics and Physics of Solids. 56(1). 267–278. 5 indexed citations
3.
Papadimitrakopoulou, V., et al.. (2005). The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis. Cancer Letters. 239(1). 136–143. 31 indexed citations
4.
Kim, E. S. & W. K. Hong. (2005). An Apple a Day...Does It Really Keep the Doctor Away? The Current State of Cancer Chemoprevention. JNCI Journal of the National Cancer Institute. 97(7). 468–470. 11 indexed citations
5.
Tsao, Anne S., E. S. Kim, & W. K. Hong. (2004). Chemoprevention of Cancer. CA A Cancer Journal for Clinicians. 54(3). 150–180. 259 indexed citations
6.
Izzo, Julie, Vassiliki A. Papadimitrakopoulou, D. D. Liu, et al.. (2003). Cyclin D1 Genotype, Response to Biochemoprevention, and Progression Rate to Upper Aerodigestive Tract Cancer. JNCI Journal of the National Cancer Institute. 95(3). 198–205. 71 indexed citations
7.
Herbst, Roy & W. K. Hong. (2002). IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer. Seminars in Oncology. 29(5). 18–30. 61 indexed citations
8.
Herbst, Roy & W. K. Hong. (2002). Introduction. Seminars in Oncology. 29(5). 1–2. 1 indexed citations
9.
Hong, W. K. & Wilhelm G. Doos. (1985). Chemoprevention of Head and Neck Cancer: Potential Use of Retinoids. Otolaryngologic Clinics of North America. 18(3). 543–549. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026